New preprint on flavivirus-host interactions with friend and collaborator Armando who spent a couple of months visiting the lab to do the interactomics with us.
Posts by Armando Arias
Buscamos candidatos para solicitar un contrato predoctoral durante la próxima convocatoria que publicará la UCLM. Si estás interesado manda un DM o un correo a armando.arias@uclm.es y adjunta CV y expediente académico
"The simultaneous detection of genetically related cVDPV2 strains in different sites in Europe further justifies keeping the PHEIC active"
www.eurosurveillance.org/content/10.2...
EXTREMELY cool and demonstrates clearly the promise of deep learning + bio.
www.nature.com/articles/s41...
Let's hope this has been/will be contained
'Germany confirms first case of foot-and-mouth disease in nearly 40 years'
www.reuters.com/business/hea...
Want to keep track of the H5 viruses that are circulating so widely, and infecting so many animals now - including cows and humans!
Identification and characterization of novel bat coronaviruses in Spain
One of the viruses can use human and bat ACE2, highlighting its zoonotic potential !
https://buff.ly/407W983
In summary, UBA1-NS5 interaction plays a significant role during flavivirus replication, and constitutes an attractive target for antiviral strategies
Treatment of infected cells with UBA1 inhibitors, including TAK243 which is being clinically trialled against other human diseases, showed an antiviral effect
UBA1 knockdown restricted Zika (and Usutu) virus replication. UBA1 overexpression led to significant increases in virus titres and viral protein levels. These data supported a proviral role for UBA1
We identified host UBA1, the main E1 enzyme participating in the ubiquitylation cascade, as an interacting factor of different flavivirus NS5s. We confirmed that UBA1 and NS5 colocalise in Zika-infected cells
Glad to see our work on the proviral activity exhibited by UBA1, a host protein interacting with Zika virus NS5, finally published on JGV doi.org/10.1099/jgv....
PhDs in biochemistry, structural biology, pharmacology, or similar, located in the US and with strong publication track records and a high motivation to solve Parkinson's, please send CV directly to me at jimhurley@berkeley.edu.
Repost appreciated.